"FDA Approves First Prescription App for Treating Depression"
The FDA has approved Rejoyn, the first app for treating major depressive disorder, to supplement traditional treatment methods. The app offers a six-week program of cognitive behavioral therapy (CBT) lessons and exercises, and is intended for adults diagnosed with depression. While Rejoyn is a significant milestone, its efficacy may vary, and consulting with a therapist is crucial to determine its suitability. Other non-prescription apps like Headspace, Woebot, and Happify also show promise in improving symptoms of depression, but they are not intended to replace professional treatment.